CA2272290C - Method for measurement of skin histology - Google Patents
Method for measurement of skin histology Download PDFInfo
- Publication number
- CA2272290C CA2272290C CA002272290A CA2272290A CA2272290C CA 2272290 C CA2272290 C CA 2272290C CA 002272290 A CA002272290 A CA 002272290A CA 2272290 A CA2272290 A CA 2272290A CA 2272290 C CA2272290 C CA 2272290C
- Authority
- CA
- Canada
- Prior art keywords
- skin
- colour
- ordinates
- melanin
- area
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/444—Evaluating skin marks, e.g. mole, nevi, tumour, scar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
Abstract
The invention relates to a method for non-invasively measuring skin structure.
Infrared radiation from a plurality of locations over an area of skin under investigation is measured so as to give an indication of the variation in papillary dermis thickness over said area, and the skin colour coordinates at a plurality of locations over the same area of skin is also measured. The data obtained is used to calculate corrected skin colour coordinates over the area corresponding to a predetermined papillary dermis thickness. The corrected skin colour coordinates so obtained are compared with a reference colour coordinate range for healthy skin of the same predetermined papillary dermis thickness. At an abnormal region, where the corrected skin colour coordinates lie outside the reference colour coordinate range, the depth of penetration of dermal melanin can be measured.
Infrared radiation from a plurality of locations over an area of skin under investigation is measured so as to give an indication of the variation in papillary dermis thickness over said area, and the skin colour coordinates at a plurality of locations over the same area of skin is also measured. The data obtained is used to calculate corrected skin colour coordinates over the area corresponding to a predetermined papillary dermis thickness. The corrected skin colour coordinates so obtained are compared with a reference colour coordinate range for healthy skin of the same predetermined papillary dermis thickness. At an abnormal region, where the corrected skin colour coordinates lie outside the reference colour coordinate range, the depth of penetration of dermal melanin can be measured.
Description
METHOD FOR MEASUREMENTOF SKIN HISTOLOGY
This invention relates to a method for the non-invasive measurement of skin histology and is particularly, but not exclusively, concerned with a method for identifying and measuring the presence and depth of dermal invasion of melanin. The presence and extent of dermal invasion within a skin cancer is considered to be the most important factor governing a patient's prognosis. The present invention is considered to be potentially useful for the preliminary screening of patients to identify those who should be referred to an appropriate clinician for diagnosis and further to assist the clinician in diagnosis.
The present invention is based on the findings reported by Symon D'O
Cotton in "Do all human skin colours lie on a defined surface within LMS
space?", University of Birmingham Technical Report, 30 December 1995.
In this Technical Report, the relation between healthy skin and the colour of the skin represented in LMS, a particular colour space, is reported, and it discloses that, for healthy skin, the coloration, regardless of race or amount of tanning, lies on a defined curved surface within a three-dimensional colour space. This, if used with a correct colour measurement system, can measure and quantify the amount of melanin and blood at any particular paint at which this measurement is made. If the skin is sampled as an image, then corresponding images showing the variation of blood and melanin across the skin can be obtained. In the above Technical Report, it is disclosed that melanin can sometimes penetrate into the dermis producing the characteristic hues of melanoma and that this melanocytic descent has been quantified by Clark et al ("The Histogenesis and Biological Behaviour of Primary Human Malignant Melanomas of the Skin", Cancer Research, 29, 1989) into five levels of tumour invasion, in which level 1 corresponds to confinement within the epidermis, level 2 corresponds to invasion into the papillary dermis, etc.
In an alternative system, the extent of tumour invasion in mm from the cornified layer is expressed as the Breslow thickness. The above Technical Report also acknowledges that, in the case of melanoma, CD
Neville ("Melanoma: Issues of Importance to the Clinician", British Journal of Hospital Medicine, March 1985) discloses the existence of a strong relationship between this level of invasion and prognosis. However, the above Technical Report does not disclose in detail any method suitable for taking the necessary measurements.
According to the present invention, there is provided a method of non-invasively analysing skin structure, comprising the steps of:
(i) measuring infrared radiation from a plurality of locations over an area of skin under investigation so as to give an indication of the variation in papillary dermis thickness over said area;
(ii) measuring the skin colour coordinates at a plurality of locations over said area of skin;
(iii) using data obtained in measuring steps (i) and (ii) to calculate corrected skin colour coordinates over said area which corresponds to a predetermined papillary dermis thickness, and;
(iv) comparing the corrected skin colour coordinates obtained in step (iii) with a reference colour coordinate range for healthy skin of the same predetermined papillary dermis thickness.
The method can be used for locating and measuring the properties of a skin abnormality, in which case the method further comprises the steps of;
WO 98!22023 PCT/GB97/03177 (v) identifying an abnormal location (i.e. a region where melanin exists within the dermis) within said area of skin where the corrected skin colour coordinates lie outside the reference colour coordinate range;
(vi) calibrating the corrected skin colour coordinates of said abnormal location with the corrected skin colour coordinates of at least one skin location having colour coordinates lying within said reference colour coordinate range for normal skin, and;
(vii) using the skin colour coordinates to assess the degree of abnormality of said abnormal skin location.
It is to be understood that using this method, it is possible to reconstruct a full 3D model of the skin architecture which conveys information grossly comparable to that available through microscopical examination of biopsied skin tissue.
It has been found that the papillary dermal skin thickness can change markedly with some skin lesions which are not otherwise of concern. This throws the coloration of the skin off the surface of predicted coloration and so can give rise to false measurements of the histology of such skin lesions. It is for this reason that papillary dermis thickness is measured first, and subsequent calculations are based on the skin colour coordinates corrected to a predetermined papillary dermis thickness. Any arbitrary value for this thickness may be chosen, such as 2.Ox10~ m which is the average value for healthy human skin.
The thickness of the papillary dermis may be obtained by utilising the property of human skin to vary its absorption of infrared radiation with varying papillary dermis thickness. In general, there is an inverse relationship between absorption and thickness. The fact that infrared radiation is also absorbed by other materials within the skin, particularly melanin and blood, is a complicating factor. However the effect on absorption of varying blood and melanin content is far smaller than the effect of papillary dermis thickness, and so the latter may still be measured. This can be done by obtaining two infrared images, each at a different wavelength. The chosen wavelengths are not important, but one should be further into the infrared (ie at longer wavelength) than the other.
Suitable wavelength bands are 800-1000nm and 600-800nm, in that readily available infrared films and filters may be used. The brightness of points within the image obtained at the longer wavelength is affected to a greater extent by variations in the papillary dermis thickness. Conversely, the image obtained at shorter wavelength will be affected to a greater extent by other materials such as melanin and blood. By predicting the brightnesses of points of differing papillary dermis thickness and amounts of epidermal melanin which absorb near-infrared radiation at the two different infrared wavelengths, a reference graph (Fag 1 ) can be obtained which consists of lines of constant papillary dermis thickness, wherein Primary 1 is the measurement made at the longer (800-1000nm) wavelength and Primary 2 is the measurement made at the shorter (b00-800nm) wavelength. The absorption of blood within these wavelengths is very small (a hundredth of its peak value for visible wavelengths at 600-800nm and even less for 800-1000nm) and to a first approximation may be ignored. The presence of dermal melanin does introduce a small error in the range of low values for both primaries, but this is insignificant in practice. Thus, by comparing values obtained at these wavelengths with this graph, it is possible to ascertain the papillary dermis thickness.
However it is within the scope of the present invention to measure brightness at such a long infra-red wavelength eg. 1100nm that the brightness would vary to such a negligible extent with melanin and blood content that it would effectively depend solely on the papillary dermis thickness. This would also reduce the error introduced by the presence of dermal melanin. In such a case only one set of brightness measurements would be required. Furthermore, a transformation can be calculated which allows an image of the skin to be created which represents how the skin would appear if it had a papillary dermis thickness of any predetermined value.
In a preferred embodiment, the reference colour coordinate range for normal skin at the predetermined papillary dermis thickness is obtained as disclosed in the above-mentioned Technical Report as a curved surface lying within a three-dimensional colour space, with one of the bounding axes relating to the amount of melanin within the epidermis and the other relating to the amount of blood within the dermis. When an area containing dermal melanin is located, i.e. points do not lie on the normal colour surface, the epidermal melanin value within this area is estimated by either reference to the reference colour coordinate range for normal skin within regions identified as normal, or by reference to the epidermal melanin levels calculated within normal regions adjacent to said area containing dermal melanin. This value is then used with the corrected colour coordinates of the abnormal region at the same predetermined papillary dermis thickness to compute invasion depth and concentration of dermal melanin. The corrected skin colour coordinates for the area of skin under investigation may be calibrated to values equivalent to zero epidermal melanin. Instead of using LMS colour space, it is possible to use any other colour space, for example, the RGB colour space or a UV G
IR colour space.
The dermis contrasts strongly in structure to that of the epidermis, being highly vascular, containing many sensory receptors and being made largely from collagen fibres to provide the essential structure of the skin.
Between the epidermis and the dermis, the junction presents an extremely uneven boundary with finger-like dermal protrusions called dermal papillae projecting towards the skin surface. The dermis can be split into two further histologically distinct layers, the papillary dermis and the reticular dermis within which the structure of the collagen fibres differs significantly. The papillary dermis is situated directly below the epidermis and within which the collagen exists as a fine network of fibres. This is in contrast with the reticular dermis where the collagen fibres are aggregated into thick bundles which are arranged nearly parallel to the skin surface.
In the case of melanin invasion of the papillary dermis, there is a layer containing blood, melanin and collagen, a layer containing either blood and collagen or melanin and collagen, depending upon whether melanin has passed the blood layer; and a layer containing just collagen. The different thicknesses of these layers, the amount of blood and the concentration of dermal melanin along with the amount of melanin in the overlying epidermis affect the remitted light. This can be modelled by calculating the net effect of these three layers for the differing parameters outlined.
A mathematical model describing the optics of the skin has been described in the above mentioned Symon D'O Cotton's Technical Report, and this model can be extended to predict coloration of skin containing dermal descent of melanin.
As can be seen from Fig 2, there are now four distinct layers within the dermis which can combine to construct a simple model, 1) a layer within the upper papillary dermis containing no melanin, 2) a layer within the upper papillary dermis containing melanin, 3) a layer within the lower papillary dermis containing melanin, 4) a layer within the lower papillary dermis containing no melanin.
It should also be noted that the condition of melanin existing up to the dermo-epidermal junction is facilitated by allowing the thickness of layer 1 to be zero and likewise melanin can exist up to the papillary-reticular dermis boundary by setting the thickness of layer 4 to be zero.
- In computing a model to predict this coloration it is useful to make note of the fact that, as discussed in section 2.1 of the Technical Report, the amount of back scatter due to melanin can be considered negligible.
Therefore, in the same manner that it was possible to apply the Kubelka-Munk theory to the papillary dermis (section 3.2.2 of the Technical Report), to compute the coloration of sections of papillary dermis containing blood, where the back scattering component of blood was considered negligible, it is possible to compute the coloration of sections containing melanin. In this situation S(~,) (scattering coefficient) remains dependent only on wavelength whilst a (fraction of radiation absorbed per unit path length) becomes a(~,,p,c~) where d~ represents the density of dermal melanin within that layer. Further, following the proof given in equation (17) of the Technical Report, a (~,,p,c~) can be shown to be the sum of a;,,(~,), ab(7~) and am(~,), where am(~,) is the absorption coefficient of melanin. From the above it is possible to calculate R and T (diffuse radiation and transmission respectively). For simplicity of notation it is helpful to consider R, & T, where, R! ~~ ~ P~ ~~ d,r ) = R( ~ (k(a ( ~~ P~ ~))~ sfS f ~ )))~ K(k~a (~ ~ P~ ~))~
s~S (~ )))~ d,. ) and T (~~ P~ ~~ d,~ ) = T(~(k(aO~ P~ ~))~s(S (~)))~ K(k(a (~~ P~ ~))~ s(S (~))), d" ) where d" is the layer thickness.
As was shown in section 3.2.3 of the Technical Report, two-layer systems can be combined to produce the total remitted and transmitted sight for the dermis resulting in equation (20) of the Technical Report.
This can be simplified using the geometric series a+ar+arz +arj+~~~- a if-1 < r < I
1-r to '' z ~.7 '' T uJ (~ ~ P ud ~ urul ) RlIr1 (~ ~ PIrl ~ ~frl ) RIIalal~~~PIrd~Plrl~~rrd~ulrl) - Rlud(~~Parl~uud)+ 1 ' 1 -~~uO~~PiaW~url)R~rJ(~~Prd~~rJ
Similarly, T,tocal can be shown to be _ ~rrd(~~P..d~~ne) ~y(~~Prn~~rd) ~roral ( ~ ~ P ud ~ P Id ~ dud ~ ~Id ) - ( /1 1 - ~lud~~~Prrd~~ud)RndO~Prn~dld) These equations can be extended, as is shown by Wan et al. [1981], to an n layered system resulting in values for R~2..." and T~z,.." of z Tlz...rr-! R., R! z...r~ = R! z...,~-! +
1- Rlz...rr-! R"
T z...n-! T
Tz...rr =
1 - R! z...rr-! Rr This system of equations can therefore compute the total remitted and transmitted light from an n layered system of arbitrary complexity provided that the thickness and composition of the layers is specified.
For the tour-layer system shown in Fig 2, this results in a value for the total light remitted and transmitted from the dermis dependent on ~,, P"d, Pld dud, drd~ drz, ~r2, dr3 and ~r3 where drZ and dr3 are the thickness of layers and 3 whilst ~,2 and ~,3 are their corresponding melanin densities. The thickness of layer 1 and layer 2 do not need to be explicitly defined as they are simply d"~-dr2 and d,~- dr3 respectively; similarly ~j, and ~r4 are zero by definition. A further simplification is possible if it is assumed that ~,2 = ~r3 leading to a single value of cb for the dermis.
The results of these equations can be combined with the predicted light transmitted by the epidermis in the same manner as that discussed in section 3.3 of the Technical Report, thus leading to the following description of total remitted, S~d, and transmitted S~~.
Sra(~~Pu~r~Prn~d~,a,dr~~d,2~y~~ ~~d,~~)=
Rzmrpr(~~P»a~Prn~~"a~~nr~drz~~r~~~)g(~~d".)zS(~) Sid(a'~Pu~l~Pr~l~uurl~urd~ur2~~I3~ ~~dnr) _ Tzrorar(~~Pud ~Prd ~dua~a'rd ~dr2,dr3~~~(~~dm)ZS(~) These can be used to predict the value of the corresponding LMS
primaries L(Prml~Pld~durl~dlol> dl2~dll~~,d,n) -w JR2lorol ( ~, P r,d , P In ~ d r,rr , d rrr ~ d,7 , d r3 ~ ~)~ ( ~, d"i ) Z
.S(~ )S,. (~ )~
M(Pr,r~~Prn,dr,a~dm~ drz,dr~,~.d"r JRzn,rr,r(~.Prm,Prrr,dr,n,drrl,drz,dr~,~)e(~,d"r)zS(~)Shr(~)~
.S(Pr.~,Prrr~dr,rr,dm, d,z,dr;,~,d",)=
JRzrr,mr(~,Pr,rr,Prrr,drm,drrr,drz,dr"~~(~,d,rr)zS(~)Ss(~)d7v, A further generalisation can be made to any primary, P", leading to the following equation where S" defines the spectral response of that primary.
p.(Pr,~~Pm,dr,n,drn~ dlz,d",~,dra) _ f IZzrrrn,r(~~~Pr,a,Pm,dr,rr,drn,drz,dry,~)e(~,d"r)z.S'(~,)5,,,(~,)d~, o , This equation can then be used~to generate the expected coloration of human skin exhibiting dermal descent of melanin.
The result of this analysis is that it is possible for the same coloration to result from different combinations of the above parameters. This complicates the measurement of the dermal invasion of melanin, (but not identifying the presence of any dermal melanin). Indeed, to obtain this measurement, it is necessary to know the amount of melanin in the overlying epidermis. However, at points where dermal invasion has taken place, this parameter is difficult to determine simply by comparing colour coordinates of the abnormal location with colour coordinates for healthy skin. It is for this reason that, in the present invention, regions where dermal melanin exists are identified by reference to a reference colour coordinate range for healthy skin, and then the colour coordinates of these regions are compared with the colour coordinates at one or more normal skin locations. If said normal skin locations are adjacent to the region where dermal melanin exists, it is sufficient to use the epidermal melanin levels calculated for such normal skin locations to estimate the epidermal melanin levels at the region where dermal melanin exists Alternatively, it is possible to perform a measurement of the epidermal melanin levels within areas of the skin where the presence of dermal melanin has been identified, by assessing the deviation in coloration at the blue end of the spectrum, from the reference colour coordinate range for normal skin due to the presence of such dermal melanin. At the blue end of the spectrum, the increase in such deviation quickly slows with increasing depth of melanin penetration until a "saturation point" is reached. 8y assuming that the depth of melanin penetration within the dermis is large enough for such saturation to have occurred, an estimate of the deviation from the reference colour coordinate range for normal skin can be made. This estimate allows a calculation to be made of the skin coloration assuming no dermal melanin, and therefore by reference to the colour coordinate range for normal skin, of the level of epidermal melanin. It is within the scope of the present invention to measure the epidermal melanin levels directly, for example using polarised light, and to incorporate such measurements in the measuring step (ii) above.
By any of the above methods, the effect of what would have been the normal epidermal melanin level in the abnormal skin location can be taken into account, thereby enabling a more accurate determination of melanin descent By comparing the values of the skin image represented in a certain colour space with theoretically calculated values covering all possible amounts of blood, dermal melanin penetration and melanin concentration within the same colour space, the values of those three parameters can be obtained for every point in the image. Since the papillary dermis thickness and epidermal melanin content are known, it is possible to compute a detailed three-dimensional reconstruction of the top layers of human skin. This is of great potential interest to the medical profession and enables routine examination of the internal structure of living skin just as X-rays, NMR and ultrasound are used for examining other parts of the body. It is also within the scope of the invention to acquire the infra-red and/ or visible images using lasers of different wavelengths or by using spectral analysis.
It is possible to use a computer programmed with the above algorithms to perform the actual calculations. However, before these calculations can be performed, an image of the area of skin under investigation must be represented in the same colour space as for the normal skin reference colour coordinate range. This can be done in a number of ways. In one way, the skin colour coordinates are acquired from an image using the same lighting conditions and a CCD camera calibrated in the same way as that used to produce the healthy skin reference colour coordinate range.
Alternatively, if exactly the same lighting conditions are not used, a white standard or other appropriate correction factor can be used to allow calibration of the image within the software. As a further alternative, a colour image can be acquired using a colour photographic film which is then digitised. This can be performed using either exactly the same lighting conditions and a calibrated set-up or again with the inclusion of a white standard or other appropriate correction factor. It is within the scope of this invention to obtain both the infra-red and visible images with a single digital camera or to calculate the value of the necessary primaries through the use of spectroscopy.
The present invention will now be described in further detail and with reference to the accompanying drawings, in which:-Fig 1 is a graph showing variation of brightness with papillary dermis thickness for primaries 1 and 2. as described hereinabove;
Fig 2 is a schematic cross-sectional view through a section of skin illustrating melanin descent into the papillary dermis;
Fig 3 is a schematic cross-sectional view through a section of skin illustrating normal, healthy regions and an abnormal region where, in this case, melanin descent into the papillary dermis and the reticular dermis has taken place;
Fig 4 is a block diagram showing the steps involved in one embodiment of the method of the present invention;
Fig 5 is a diagram showing the predicted surface of normal skin coloration within a three-dimensional colour space;
Fig 6 is a diagram showing coloration within the skin cancer that is shown in Fig 7 in the same 3-D colour space as depicted in Fig 5, wherein areas of normal and abnormal coloration are shown; and Fig 7 is a photographic image of the skin cancer.
Referring now to Fig 3 of the drawings, a schematic skin section is shown wherein melanin (indicated by the black circles in Fig 3) in normal healthy skin are present in the lower part of epidermis 10 adjacent but above the dermo-epidermal junction 12 between the epidermis and the papillary dermis 14. The Breslow thickness referred to above is the depth of melanin invasion in millimetres measured from granular layer 16 which is a layer in the epidermis 10 where he skin goes scaly and forms the tough outer cornified layer 18. 1n the abnormal region of the skin, the melanin is shown as having descended not only into the papillary dermis 14, but also into the underlying reticular dermis 20 lying above the subcutaneous fat layer 22. It is to be appreciated that, in other cases, melanin decent can be into any layer of the skin and may even be into the subcutaneous fat layer 22.
Referring now to Fig 4, there is shown a block diagram illustrating the steps involved in a typical method of measurement in accordance with the present invention. fn Fig 4, Block 40 exemplifies method step (ii) above- the acquisition of an image at visible wavelengths of the same skin area. This can be by CCD camera, digitised film or any other convenient means. Block 42 exemplifies method step (iii) above- the transformation of the image into corrected colour space of the skin model at a predetermined papillary dermis thickness. Block 44 exemplifies method steps (iv and v) above- the identification of regions containing dermal melanin, by comparing the corrected skin colour coordinates with the reference colour coordinate range. Block 46 exemplifies method step (vi) above- use of the corrected colour space to calculate the amounts of epidermal melanin within normal regions adjacent to the regions containing dermal melanin and use thereof to give an indication of the amounts thereof which exist in the regions containing dermal melanin. Block 48 exemplifies a first part of method step (vii) above- calculation of dermal invasion using the measured coloration of the abnormal regions and the calculated amount of epidermal melanin from 46. Block 50 exemplifies a second part of method step (vii) above- transformation of the calculated dermal invasion of melanin into either the Breslow thickness or the Clark's level of invasion. This can be reported as either representing the maximum invasion or as an image showing invasion over the skin.
Referring now to Fig 5, the shaded surface indicates the range of colorations which can exist in normal healthy skin corrected to the predetermined papillary dermis thickness. Skin colorations which depart from this surface are indicative of dermal melanin.
Referring now to Figs. 6 and 7, it can be seen that a region of the skin which is shown in Fig 7 and which is indicated by arrow H in Fig 6 lies at a position corresponding to part of the shaded surface illustrated in Fig 5 and is indicative of normal healthy skin, whereas an adjacent region indicated by arrow U in Fig 6 lies outside such surface and is indicative of skin containing dermal melanin. Comparison of the coloration of these two adjacent regions H and U enables the depth of melanin invasion in the abnormal region of the skin in Fig 7 to be computed.
This invention relates to a method for the non-invasive measurement of skin histology and is particularly, but not exclusively, concerned with a method for identifying and measuring the presence and depth of dermal invasion of melanin. The presence and extent of dermal invasion within a skin cancer is considered to be the most important factor governing a patient's prognosis. The present invention is considered to be potentially useful for the preliminary screening of patients to identify those who should be referred to an appropriate clinician for diagnosis and further to assist the clinician in diagnosis.
The present invention is based on the findings reported by Symon D'O
Cotton in "Do all human skin colours lie on a defined surface within LMS
space?", University of Birmingham Technical Report, 30 December 1995.
In this Technical Report, the relation between healthy skin and the colour of the skin represented in LMS, a particular colour space, is reported, and it discloses that, for healthy skin, the coloration, regardless of race or amount of tanning, lies on a defined curved surface within a three-dimensional colour space. This, if used with a correct colour measurement system, can measure and quantify the amount of melanin and blood at any particular paint at which this measurement is made. If the skin is sampled as an image, then corresponding images showing the variation of blood and melanin across the skin can be obtained. In the above Technical Report, it is disclosed that melanin can sometimes penetrate into the dermis producing the characteristic hues of melanoma and that this melanocytic descent has been quantified by Clark et al ("The Histogenesis and Biological Behaviour of Primary Human Malignant Melanomas of the Skin", Cancer Research, 29, 1989) into five levels of tumour invasion, in which level 1 corresponds to confinement within the epidermis, level 2 corresponds to invasion into the papillary dermis, etc.
In an alternative system, the extent of tumour invasion in mm from the cornified layer is expressed as the Breslow thickness. The above Technical Report also acknowledges that, in the case of melanoma, CD
Neville ("Melanoma: Issues of Importance to the Clinician", British Journal of Hospital Medicine, March 1985) discloses the existence of a strong relationship between this level of invasion and prognosis. However, the above Technical Report does not disclose in detail any method suitable for taking the necessary measurements.
According to the present invention, there is provided a method of non-invasively analysing skin structure, comprising the steps of:
(i) measuring infrared radiation from a plurality of locations over an area of skin under investigation so as to give an indication of the variation in papillary dermis thickness over said area;
(ii) measuring the skin colour coordinates at a plurality of locations over said area of skin;
(iii) using data obtained in measuring steps (i) and (ii) to calculate corrected skin colour coordinates over said area which corresponds to a predetermined papillary dermis thickness, and;
(iv) comparing the corrected skin colour coordinates obtained in step (iii) with a reference colour coordinate range for healthy skin of the same predetermined papillary dermis thickness.
The method can be used for locating and measuring the properties of a skin abnormality, in which case the method further comprises the steps of;
WO 98!22023 PCT/GB97/03177 (v) identifying an abnormal location (i.e. a region where melanin exists within the dermis) within said area of skin where the corrected skin colour coordinates lie outside the reference colour coordinate range;
(vi) calibrating the corrected skin colour coordinates of said abnormal location with the corrected skin colour coordinates of at least one skin location having colour coordinates lying within said reference colour coordinate range for normal skin, and;
(vii) using the skin colour coordinates to assess the degree of abnormality of said abnormal skin location.
It is to be understood that using this method, it is possible to reconstruct a full 3D model of the skin architecture which conveys information grossly comparable to that available through microscopical examination of biopsied skin tissue.
It has been found that the papillary dermal skin thickness can change markedly with some skin lesions which are not otherwise of concern. This throws the coloration of the skin off the surface of predicted coloration and so can give rise to false measurements of the histology of such skin lesions. It is for this reason that papillary dermis thickness is measured first, and subsequent calculations are based on the skin colour coordinates corrected to a predetermined papillary dermis thickness. Any arbitrary value for this thickness may be chosen, such as 2.Ox10~ m which is the average value for healthy human skin.
The thickness of the papillary dermis may be obtained by utilising the property of human skin to vary its absorption of infrared radiation with varying papillary dermis thickness. In general, there is an inverse relationship between absorption and thickness. The fact that infrared radiation is also absorbed by other materials within the skin, particularly melanin and blood, is a complicating factor. However the effect on absorption of varying blood and melanin content is far smaller than the effect of papillary dermis thickness, and so the latter may still be measured. This can be done by obtaining two infrared images, each at a different wavelength. The chosen wavelengths are not important, but one should be further into the infrared (ie at longer wavelength) than the other.
Suitable wavelength bands are 800-1000nm and 600-800nm, in that readily available infrared films and filters may be used. The brightness of points within the image obtained at the longer wavelength is affected to a greater extent by variations in the papillary dermis thickness. Conversely, the image obtained at shorter wavelength will be affected to a greater extent by other materials such as melanin and blood. By predicting the brightnesses of points of differing papillary dermis thickness and amounts of epidermal melanin which absorb near-infrared radiation at the two different infrared wavelengths, a reference graph (Fag 1 ) can be obtained which consists of lines of constant papillary dermis thickness, wherein Primary 1 is the measurement made at the longer (800-1000nm) wavelength and Primary 2 is the measurement made at the shorter (b00-800nm) wavelength. The absorption of blood within these wavelengths is very small (a hundredth of its peak value for visible wavelengths at 600-800nm and even less for 800-1000nm) and to a first approximation may be ignored. The presence of dermal melanin does introduce a small error in the range of low values for both primaries, but this is insignificant in practice. Thus, by comparing values obtained at these wavelengths with this graph, it is possible to ascertain the papillary dermis thickness.
However it is within the scope of the present invention to measure brightness at such a long infra-red wavelength eg. 1100nm that the brightness would vary to such a negligible extent with melanin and blood content that it would effectively depend solely on the papillary dermis thickness. This would also reduce the error introduced by the presence of dermal melanin. In such a case only one set of brightness measurements would be required. Furthermore, a transformation can be calculated which allows an image of the skin to be created which represents how the skin would appear if it had a papillary dermis thickness of any predetermined value.
In a preferred embodiment, the reference colour coordinate range for normal skin at the predetermined papillary dermis thickness is obtained as disclosed in the above-mentioned Technical Report as a curved surface lying within a three-dimensional colour space, with one of the bounding axes relating to the amount of melanin within the epidermis and the other relating to the amount of blood within the dermis. When an area containing dermal melanin is located, i.e. points do not lie on the normal colour surface, the epidermal melanin value within this area is estimated by either reference to the reference colour coordinate range for normal skin within regions identified as normal, or by reference to the epidermal melanin levels calculated within normal regions adjacent to said area containing dermal melanin. This value is then used with the corrected colour coordinates of the abnormal region at the same predetermined papillary dermis thickness to compute invasion depth and concentration of dermal melanin. The corrected skin colour coordinates for the area of skin under investigation may be calibrated to values equivalent to zero epidermal melanin. Instead of using LMS colour space, it is possible to use any other colour space, for example, the RGB colour space or a UV G
IR colour space.
The dermis contrasts strongly in structure to that of the epidermis, being highly vascular, containing many sensory receptors and being made largely from collagen fibres to provide the essential structure of the skin.
Between the epidermis and the dermis, the junction presents an extremely uneven boundary with finger-like dermal protrusions called dermal papillae projecting towards the skin surface. The dermis can be split into two further histologically distinct layers, the papillary dermis and the reticular dermis within which the structure of the collagen fibres differs significantly. The papillary dermis is situated directly below the epidermis and within which the collagen exists as a fine network of fibres. This is in contrast with the reticular dermis where the collagen fibres are aggregated into thick bundles which are arranged nearly parallel to the skin surface.
In the case of melanin invasion of the papillary dermis, there is a layer containing blood, melanin and collagen, a layer containing either blood and collagen or melanin and collagen, depending upon whether melanin has passed the blood layer; and a layer containing just collagen. The different thicknesses of these layers, the amount of blood and the concentration of dermal melanin along with the amount of melanin in the overlying epidermis affect the remitted light. This can be modelled by calculating the net effect of these three layers for the differing parameters outlined.
A mathematical model describing the optics of the skin has been described in the above mentioned Symon D'O Cotton's Technical Report, and this model can be extended to predict coloration of skin containing dermal descent of melanin.
As can be seen from Fig 2, there are now four distinct layers within the dermis which can combine to construct a simple model, 1) a layer within the upper papillary dermis containing no melanin, 2) a layer within the upper papillary dermis containing melanin, 3) a layer within the lower papillary dermis containing melanin, 4) a layer within the lower papillary dermis containing no melanin.
It should also be noted that the condition of melanin existing up to the dermo-epidermal junction is facilitated by allowing the thickness of layer 1 to be zero and likewise melanin can exist up to the papillary-reticular dermis boundary by setting the thickness of layer 4 to be zero.
- In computing a model to predict this coloration it is useful to make note of the fact that, as discussed in section 2.1 of the Technical Report, the amount of back scatter due to melanin can be considered negligible.
Therefore, in the same manner that it was possible to apply the Kubelka-Munk theory to the papillary dermis (section 3.2.2 of the Technical Report), to compute the coloration of sections of papillary dermis containing blood, where the back scattering component of blood was considered negligible, it is possible to compute the coloration of sections containing melanin. In this situation S(~,) (scattering coefficient) remains dependent only on wavelength whilst a (fraction of radiation absorbed per unit path length) becomes a(~,,p,c~) where d~ represents the density of dermal melanin within that layer. Further, following the proof given in equation (17) of the Technical Report, a (~,,p,c~) can be shown to be the sum of a;,,(~,), ab(7~) and am(~,), where am(~,) is the absorption coefficient of melanin. From the above it is possible to calculate R and T (diffuse radiation and transmission respectively). For simplicity of notation it is helpful to consider R, & T, where, R! ~~ ~ P~ ~~ d,r ) = R( ~ (k(a ( ~~ P~ ~))~ sfS f ~ )))~ K(k~a (~ ~ P~ ~))~
s~S (~ )))~ d,. ) and T (~~ P~ ~~ d,~ ) = T(~(k(aO~ P~ ~))~s(S (~)))~ K(k(a (~~ P~ ~))~ s(S (~))), d" ) where d" is the layer thickness.
As was shown in section 3.2.3 of the Technical Report, two-layer systems can be combined to produce the total remitted and transmitted sight for the dermis resulting in equation (20) of the Technical Report.
This can be simplified using the geometric series a+ar+arz +arj+~~~- a if-1 < r < I
1-r to '' z ~.7 '' T uJ (~ ~ P ud ~ urul ) RlIr1 (~ ~ PIrl ~ ~frl ) RIIalal~~~PIrd~Plrl~~rrd~ulrl) - Rlud(~~Parl~uud)+ 1 ' 1 -~~uO~~PiaW~url)R~rJ(~~Prd~~rJ
Similarly, T,tocal can be shown to be _ ~rrd(~~P..d~~ne) ~y(~~Prn~~rd) ~roral ( ~ ~ P ud ~ P Id ~ dud ~ ~Id ) - ( /1 1 - ~lud~~~Prrd~~ud)RndO~Prn~dld) These equations can be extended, as is shown by Wan et al. [1981], to an n layered system resulting in values for R~2..." and T~z,.." of z Tlz...rr-! R., R! z...r~ = R! z...,~-! +
1- Rlz...rr-! R"
T z...n-! T
Tz...rr =
1 - R! z...rr-! Rr This system of equations can therefore compute the total remitted and transmitted light from an n layered system of arbitrary complexity provided that the thickness and composition of the layers is specified.
For the tour-layer system shown in Fig 2, this results in a value for the total light remitted and transmitted from the dermis dependent on ~,, P"d, Pld dud, drd~ drz, ~r2, dr3 and ~r3 where drZ and dr3 are the thickness of layers and 3 whilst ~,2 and ~,3 are their corresponding melanin densities. The thickness of layer 1 and layer 2 do not need to be explicitly defined as they are simply d"~-dr2 and d,~- dr3 respectively; similarly ~j, and ~r4 are zero by definition. A further simplification is possible if it is assumed that ~,2 = ~r3 leading to a single value of cb for the dermis.
The results of these equations can be combined with the predicted light transmitted by the epidermis in the same manner as that discussed in section 3.3 of the Technical Report, thus leading to the following description of total remitted, S~d, and transmitted S~~.
Sra(~~Pu~r~Prn~d~,a,dr~~d,2~y~~ ~~d,~~)=
Rzmrpr(~~P»a~Prn~~"a~~nr~drz~~r~~~)g(~~d".)zS(~) Sid(a'~Pu~l~Pr~l~uurl~urd~ur2~~I3~ ~~dnr) _ Tzrorar(~~Pud ~Prd ~dua~a'rd ~dr2,dr3~~~(~~dm)ZS(~) These can be used to predict the value of the corresponding LMS
primaries L(Prml~Pld~durl~dlol> dl2~dll~~,d,n) -w JR2lorol ( ~, P r,d , P In ~ d r,rr , d rrr ~ d,7 , d r3 ~ ~)~ ( ~, d"i ) Z
.S(~ )S,. (~ )~
M(Pr,r~~Prn,dr,a~dm~ drz,dr~,~.d"r JRzn,rr,r(~.Prm,Prrr,dr,n,drrl,drz,dr~,~)e(~,d"r)zS(~)Shr(~)~
.S(Pr.~,Prrr~dr,rr,dm, d,z,dr;,~,d",)=
JRzrr,mr(~,Pr,rr,Prrr,drm,drrr,drz,dr"~~(~,d,rr)zS(~)Ss(~)d7v, A further generalisation can be made to any primary, P", leading to the following equation where S" defines the spectral response of that primary.
p.(Pr,~~Pm,dr,n,drn~ dlz,d",~,dra) _ f IZzrrrn,r(~~~Pr,a,Pm,dr,rr,drn,drz,dry,~)e(~,d"r)z.S'(~,)5,,,(~,)d~, o , This equation can then be used~to generate the expected coloration of human skin exhibiting dermal descent of melanin.
The result of this analysis is that it is possible for the same coloration to result from different combinations of the above parameters. This complicates the measurement of the dermal invasion of melanin, (but not identifying the presence of any dermal melanin). Indeed, to obtain this measurement, it is necessary to know the amount of melanin in the overlying epidermis. However, at points where dermal invasion has taken place, this parameter is difficult to determine simply by comparing colour coordinates of the abnormal location with colour coordinates for healthy skin. It is for this reason that, in the present invention, regions where dermal melanin exists are identified by reference to a reference colour coordinate range for healthy skin, and then the colour coordinates of these regions are compared with the colour coordinates at one or more normal skin locations. If said normal skin locations are adjacent to the region where dermal melanin exists, it is sufficient to use the epidermal melanin levels calculated for such normal skin locations to estimate the epidermal melanin levels at the region where dermal melanin exists Alternatively, it is possible to perform a measurement of the epidermal melanin levels within areas of the skin where the presence of dermal melanin has been identified, by assessing the deviation in coloration at the blue end of the spectrum, from the reference colour coordinate range for normal skin due to the presence of such dermal melanin. At the blue end of the spectrum, the increase in such deviation quickly slows with increasing depth of melanin penetration until a "saturation point" is reached. 8y assuming that the depth of melanin penetration within the dermis is large enough for such saturation to have occurred, an estimate of the deviation from the reference colour coordinate range for normal skin can be made. This estimate allows a calculation to be made of the skin coloration assuming no dermal melanin, and therefore by reference to the colour coordinate range for normal skin, of the level of epidermal melanin. It is within the scope of the present invention to measure the epidermal melanin levels directly, for example using polarised light, and to incorporate such measurements in the measuring step (ii) above.
By any of the above methods, the effect of what would have been the normal epidermal melanin level in the abnormal skin location can be taken into account, thereby enabling a more accurate determination of melanin descent By comparing the values of the skin image represented in a certain colour space with theoretically calculated values covering all possible amounts of blood, dermal melanin penetration and melanin concentration within the same colour space, the values of those three parameters can be obtained for every point in the image. Since the papillary dermis thickness and epidermal melanin content are known, it is possible to compute a detailed three-dimensional reconstruction of the top layers of human skin. This is of great potential interest to the medical profession and enables routine examination of the internal structure of living skin just as X-rays, NMR and ultrasound are used for examining other parts of the body. It is also within the scope of the invention to acquire the infra-red and/ or visible images using lasers of different wavelengths or by using spectral analysis.
It is possible to use a computer programmed with the above algorithms to perform the actual calculations. However, before these calculations can be performed, an image of the area of skin under investigation must be represented in the same colour space as for the normal skin reference colour coordinate range. This can be done in a number of ways. In one way, the skin colour coordinates are acquired from an image using the same lighting conditions and a CCD camera calibrated in the same way as that used to produce the healthy skin reference colour coordinate range.
Alternatively, if exactly the same lighting conditions are not used, a white standard or other appropriate correction factor can be used to allow calibration of the image within the software. As a further alternative, a colour image can be acquired using a colour photographic film which is then digitised. This can be performed using either exactly the same lighting conditions and a calibrated set-up or again with the inclusion of a white standard or other appropriate correction factor. It is within the scope of this invention to obtain both the infra-red and visible images with a single digital camera or to calculate the value of the necessary primaries through the use of spectroscopy.
The present invention will now be described in further detail and with reference to the accompanying drawings, in which:-Fig 1 is a graph showing variation of brightness with papillary dermis thickness for primaries 1 and 2. as described hereinabove;
Fig 2 is a schematic cross-sectional view through a section of skin illustrating melanin descent into the papillary dermis;
Fig 3 is a schematic cross-sectional view through a section of skin illustrating normal, healthy regions and an abnormal region where, in this case, melanin descent into the papillary dermis and the reticular dermis has taken place;
Fig 4 is a block diagram showing the steps involved in one embodiment of the method of the present invention;
Fig 5 is a diagram showing the predicted surface of normal skin coloration within a three-dimensional colour space;
Fig 6 is a diagram showing coloration within the skin cancer that is shown in Fig 7 in the same 3-D colour space as depicted in Fig 5, wherein areas of normal and abnormal coloration are shown; and Fig 7 is a photographic image of the skin cancer.
Referring now to Fig 3 of the drawings, a schematic skin section is shown wherein melanin (indicated by the black circles in Fig 3) in normal healthy skin are present in the lower part of epidermis 10 adjacent but above the dermo-epidermal junction 12 between the epidermis and the papillary dermis 14. The Breslow thickness referred to above is the depth of melanin invasion in millimetres measured from granular layer 16 which is a layer in the epidermis 10 where he skin goes scaly and forms the tough outer cornified layer 18. 1n the abnormal region of the skin, the melanin is shown as having descended not only into the papillary dermis 14, but also into the underlying reticular dermis 20 lying above the subcutaneous fat layer 22. It is to be appreciated that, in other cases, melanin decent can be into any layer of the skin and may even be into the subcutaneous fat layer 22.
Referring now to Fig 4, there is shown a block diagram illustrating the steps involved in a typical method of measurement in accordance with the present invention. fn Fig 4, Block 40 exemplifies method step (ii) above- the acquisition of an image at visible wavelengths of the same skin area. This can be by CCD camera, digitised film or any other convenient means. Block 42 exemplifies method step (iii) above- the transformation of the image into corrected colour space of the skin model at a predetermined papillary dermis thickness. Block 44 exemplifies method steps (iv and v) above- the identification of regions containing dermal melanin, by comparing the corrected skin colour coordinates with the reference colour coordinate range. Block 46 exemplifies method step (vi) above- use of the corrected colour space to calculate the amounts of epidermal melanin within normal regions adjacent to the regions containing dermal melanin and use thereof to give an indication of the amounts thereof which exist in the regions containing dermal melanin. Block 48 exemplifies a first part of method step (vii) above- calculation of dermal invasion using the measured coloration of the abnormal regions and the calculated amount of epidermal melanin from 46. Block 50 exemplifies a second part of method step (vii) above- transformation of the calculated dermal invasion of melanin into either the Breslow thickness or the Clark's level of invasion. This can be reported as either representing the maximum invasion or as an image showing invasion over the skin.
Referring now to Fig 5, the shaded surface indicates the range of colorations which can exist in normal healthy skin corrected to the predetermined papillary dermis thickness. Skin colorations which depart from this surface are indicative of dermal melanin.
Referring now to Figs. 6 and 7, it can be seen that a region of the skin which is shown in Fig 7 and which is indicated by arrow H in Fig 6 lies at a position corresponding to part of the shaded surface illustrated in Fig 5 and is indicative of normal healthy skin, whereas an adjacent region indicated by arrow U in Fig 6 lies outside such surface and is indicative of skin containing dermal melanin. Comparison of the coloration of these two adjacent regions H and U enables the depth of melanin invasion in the abnormal region of the skin in Fig 7 to be computed.
Claims (15)
1. A method of non-invasively analysing skin structure, comprising the steps of:
(i) measuring red or infrared radiation having a wavelength of at least 600 nm from at least one location in an area of skin under investigation so as to give an indication of a papillary dermis thickness in said area;
(ii) measuring skin colour co-ordinates at said at least one location in said area of skin;
(iii) using data obtained in measuring steps (i) and (iii) to calculate corrected skin colour co-ordinates in respect of the or at least one said area which corresponds to a predetermined papillary dermis thickness, and;
(iv) comparing the corrected skin colour co-ordinates obtained in step (iii) with a reference colour co-ordinate range for healthy skin of the same predetermined papillary dermis thickness.
(i) measuring red or infrared radiation having a wavelength of at least 600 nm from at least one location in an area of skin under investigation so as to give an indication of a papillary dermis thickness in said area;
(ii) measuring skin colour co-ordinates at said at least one location in said area of skin;
(iii) using data obtained in measuring steps (i) and (iii) to calculate corrected skin colour co-ordinates in respect of the or at least one said area which corresponds to a predetermined papillary dermis thickness, and;
(iv) comparing the corrected skin colour co-ordinates obtained in step (iii) with a reference colour co-ordinate range for healthy skin of the same predetermined papillary dermis thickness.
2. A method according to claim 1, comprising the additional steps of:
(v) identifying an abnormal location within said area of skin where the corrected skin colour co-ordinates lie outside the reference colour co-ordinate range;
(vi) calibrating the corrected skin colour co-ordinates of said abnormal location with the corrected skin colour co-ordinates of at least one skin location having colour co-ordinates lying within said reference colour co-ordinate range for normal skin; and (vii) using the skin colour co-ordinates to assess a degree of abnormality of said abnormal skin location.
(v) identifying an abnormal location within said area of skin where the corrected skin colour co-ordinates lie outside the reference colour co-ordinate range;
(vi) calibrating the corrected skin colour co-ordinates of said abnormal location with the corrected skin colour co-ordinates of at least one skin location having colour co-ordinates lying within said reference colour co-ordinate range for normal skin; and (vii) using the skin colour co-ordinates to assess a degree of abnormality of said abnormal skin location.
3. A method according to claim 1 or 2, wherein an independent measurement of a level of epidermal melanin is made.
4. A method according to claim 3, wherein said independent measurement of the level of epidermal melanin is by polarized light.
5. A method according to claim 2, wherein said calibration in step (vi) includes estimating the level of epidermal melanin in said abnormal location by reference to epidermal melanin levels calculated within at least one normal skin location adjacent said abnormal region.
6. A method according to claim 2, wherein said calibration in step (vi) includes measuring epidermal melanin levels at said abnormal location by assessing a deviation at the blue end of the spectrum at said abnormal location from the reference colour co-ordinate range for normal skin.
7. A method according to any one of claims 1 to 6, wherein in step (i), a single infrared image at a wavelength of greater than about 1100 nm is obtained for the or each of said locations.
8. A method according to any one of claims 1 to 6, wherein in step (i) two images, each at a different wavelength, are obtained for the or each of said locations, thereby to enable the effect of a presence of epidermal melanin and dermal blood to be accounted for in the calculation of step (iii).
9. A method according to claim 8, wherein said wavelengths fall within the bands 800-1000 nm and 600-800 nm respectively.
10. A method according to any one of claims 7 to 9, wherein said infrared image(s) is/are obtained using infrared photographic film, or laser(s), or by spectral analysis.
11. A method according to any one of claims 1 to 10, wherein the reference colour co-ordinate range for normal skin at the predetermined papillary dermis thickness referred to in step (iv), is obtained as a curved surface lying within a three-dimensional colour space, with a first bounding axis relating to an amount of melanin within the epidermis and a second and a second bounding axis relating to an amount of blood within the dermis.
12. A method according to claim 11, wherein said three-dimensional colour space is selected from LMS colour space, RGB
colour space and UV G IR colour space.
colour space and UV G IR colour space.
13. A method according to any one of claims 1 to 12, wherein the skin colour co-ordinates of step (ii) are acquired from an image using lighting conditions and the same calibration set-up as used to produce a healthy skin reference colour co-ordinate range.
14. A method according to any one of claims 1 to 12, wherein skin colour co-ordinates of step (ii) are acquired from an image using different lighting conditions than used to obtain the healthy skin reference colour co-ordinate range, and a white standard or other correction factor is used to allow calibration of the image with the reference colour co-ordinate range.
15. An apparatus for non-invasively analysing skin structure, comprising:
means for projecting red radiation or infrared radiation, or both, onto an area of skin under investigation;
measuring means for measuring remitted red or infrared radiation from at least one location over said area of skin so as to give an indication of the papillary dermis thickness in said area;
skin colour co-ordinate measuring means for measuring the skin colour co-ordinates at said at least one location in said area of skin;
calculating means for using data obtained in measuring steps (i) and (ii) to calculate corrected skin colour co-ordinates in respect of the or at least one said area which corresponds to a predetermined papillary dermis thickness, and;
colour comparison means for comparing the corrected skin colour co-ordinates obtained in step (iii) with a reference colour co-ordinate range for healthy skin of the same predetermined papillary dermis thickness.
means for projecting red radiation or infrared radiation, or both, onto an area of skin under investigation;
measuring means for measuring remitted red or infrared radiation from at least one location over said area of skin so as to give an indication of the papillary dermis thickness in said area;
skin colour co-ordinate measuring means for measuring the skin colour co-ordinates at said at least one location in said area of skin;
calculating means for using data obtained in measuring steps (i) and (ii) to calculate corrected skin colour co-ordinates in respect of the or at least one said area which corresponds to a predetermined papillary dermis thickness, and;
colour comparison means for comparing the corrected skin colour co-ordinates obtained in step (iii) with a reference colour co-ordinate range for healthy skin of the same predetermined papillary dermis thickness.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9624003.1 | 1996-11-19 | ||
| GBGB9624003.1A GB9624003D0 (en) | 1996-11-19 | 1996-11-19 | Method and apparatus for measurement of skin histology |
| PCT/GB1997/003177 WO1998022023A1 (en) | 1996-11-19 | 1997-11-19 | Method for measurement of skin histology |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2272290A1 CA2272290A1 (en) | 1998-05-28 |
| CA2272290C true CA2272290C (en) | 2006-02-07 |
Family
ID=10803145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002272290A Expired - Fee Related CA2272290C (en) | 1996-11-19 | 1997-11-19 | Method for measurement of skin histology |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6324417B1 (en) |
| EP (1) | EP1006876B1 (en) |
| JP (1) | JP2001504020A (en) |
| AT (1) | ATE217172T1 (en) |
| AU (1) | AU725766B2 (en) |
| BR (1) | BR9713097A (en) |
| CA (1) | CA2272290C (en) |
| DE (1) | DE69712533T2 (en) |
| ES (1) | ES2175373T3 (en) |
| GB (2) | GB9624003D0 (en) |
| IL (1) | IL130008A (en) |
| WO (1) | WO1998022023A1 (en) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5232100A (en) * | 1999-06-04 | 2000-12-28 | Astron Clinica Limited | Method of and apparatus for investigating tissue histology |
| GB2396007A (en) * | 1999-06-04 | 2004-06-09 | Astron Clinica Ltd | Method of and apparatus for investigating tissue histology |
| US7280866B1 (en) | 1999-10-06 | 2007-10-09 | National Research Council Of Canada | Non-invasive screening of skin diseases by visible/near-infrared spectroscopy |
| US20010041829A1 (en) * | 2000-01-12 | 2001-11-15 | Suresh Thennadil | Non-invasive method of determining skin thickness and characterizing layers of skin tissue in vivo |
| CA2398278C (en) | 2000-01-27 | 2012-05-15 | National Research Council Of Canada | Visible-near infrared spectroscopy in burn injury assessment |
| GB2361994B (en) * | 2000-05-06 | 2004-12-08 | Astron Clinica Ltd | Apparatus and methods for analysing skin histology |
| EP1296593A2 (en) * | 2000-07-05 | 2003-04-02 | Astron Clinica Limited | Ephitelial diagnostic aid |
| GB2364567A (en) * | 2000-07-07 | 2002-01-30 | Astron Clinica Ltd | Determining distribution of chromophores in skin or other epithelial tissue |
| GB2364376A (en) * | 2000-07-05 | 2002-01-23 | Astron Clinica Ltd | Skin illumination and examination apparatus |
| NO325061B1 (en) * | 2001-03-06 | 2008-01-28 | Photosense As | Method and arrangement for determining the optical property of a multilayer tissue |
| US7024037B2 (en) * | 2002-03-22 | 2006-04-04 | Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. | Cross-polarized imaging method for measuring skin ashing |
| WO2004010118A1 (en) * | 2002-07-19 | 2004-01-29 | Astron Clinica Limited | Method and apparatus for investigating histology of epithelial tissue |
| GB0217570D0 (en) | 2002-07-30 | 2002-09-11 | Univ Birmingham | Method and apparatus for quantifying material or object properties |
| AU2003255745B2 (en) * | 2002-07-30 | 2007-03-22 | Medx Health Corporation | Method and apparatus for quantifying tissue histology |
| GB0225060D0 (en) * | 2002-10-29 | 2002-12-04 | Astron Clinica Ltd | Methods and apparatus for measuring tissue histology |
| SE0401004D0 (en) | 2004-04-19 | 2004-04-19 | Gert Nilsson | Non-invasive method to monitor microcalculation |
| US20060241495A1 (en) * | 2005-03-23 | 2006-10-26 | Eastman Kodak Company | Wound healing monitoring and treatment |
| US20080218732A1 (en) * | 2005-07-27 | 2008-09-11 | University Of Massachusetts Lowell | Infrared Scanner for Biological Applications |
| GB2429385C (en) * | 2005-09-23 | 2008-04-24 | Astron Clinica Ltd | Image processing method and apparatus. |
| AU2006300008A1 (en) | 2005-10-14 | 2007-04-19 | Applied Research Associates Nz Limited | A method of monitoring a surface feature and apparatus therefor |
| GB2429523B (en) | 2005-12-23 | 2008-03-26 | Astron Clinica Ltd | Method and apparatus for detecting the presence of dermal melanin in epithelial tissue |
| EP2530168B1 (en) | 2006-05-11 | 2015-09-16 | Raindance Technologies, Inc. | Microfluidic Devices |
| US9074242B2 (en) | 2010-02-12 | 2015-07-07 | Raindance Technologies, Inc. | Digital analyte analysis |
| US8000777B2 (en) * | 2006-09-19 | 2011-08-16 | Kci Licensing, Inc. | System and method for tracking healing progress of tissue |
| GB2443389A (en) * | 2006-11-03 | 2008-05-07 | Astron Clinica Ltd | Method and apparatus for obtaining a measurement of sun damage |
| US8772046B2 (en) | 2007-02-06 | 2014-07-08 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
| US8592221B2 (en) | 2007-04-19 | 2013-11-26 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
| EP2005886B1 (en) * | 2007-06-19 | 2011-09-14 | Biocompatibles UK Limited | Method and apparatus for measuring skin texture |
| DE602007014218D1 (en) * | 2007-09-20 | 2011-06-09 | Biocompatibles Uk Ltd | Apparatus and method for measuring collagen thickness |
| AU2009206293B2 (en) * | 2008-01-24 | 2014-05-01 | Balter, Inc. | Method for discriminating between malignant and benign tissue lesions |
| US20110160563A1 (en) * | 2008-02-26 | 2011-06-30 | Glogau Richard G | Diagnostic skin mapping by mrs, mri and other methods |
| CA2718906C (en) * | 2008-03-18 | 2018-09-11 | Balter, Inc. | Optical method for determining morphological parameters and physiological properties of tissue |
| EP4047367A1 (en) | 2008-07-18 | 2022-08-24 | Bio-Rad Laboratories, Inc. | Method for detecting target analytes with droplet libraries |
| GB0904080D0 (en) | 2009-03-09 | 2009-04-22 | Mologic Ltd | Imaging method |
| JP5323600B2 (en) * | 2009-07-17 | 2013-10-23 | 花王株式会社 | Measuring method of stratum corneum thickness |
| JP5635762B2 (en) * | 2009-11-11 | 2014-12-03 | ポーラ化成工業株式会社 | Method for calculating nipple shape or collagen-like structure |
| US9399797B2 (en) | 2010-02-12 | 2016-07-26 | Raindance Technologies, Inc. | Digital analyte analysis |
| WO2012112804A1 (en) | 2011-02-18 | 2012-08-23 | Raindance Technoligies, Inc. | Compositions and methods for molecular labeling |
| WO2012167142A2 (en) | 2011-06-02 | 2012-12-06 | Raindance Technolgies, Inc. | Enzyme quantification |
| US8658430B2 (en) | 2011-07-20 | 2014-02-25 | Raindance Technologies, Inc. | Manipulating droplet size |
| US9179844B2 (en) | 2011-11-28 | 2015-11-10 | Aranz Healthcare Limited | Handheld skin measuring or monitoring device |
| US9001326B2 (en) | 2011-12-13 | 2015-04-07 | Welch Allyn, Inc. | Method and apparatus for observing subsurfaces of a target material |
| JP6131597B2 (en) * | 2012-12-28 | 2017-05-24 | 花王株式会社 | Skin evaluation method and skin evaluation system |
| AU2014212124A1 (en) * | 2013-02-01 | 2015-09-10 | Daniel FARKAS | Method and system for characterizing tissue in three dimensions using multimode optical measurements |
| US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
| US9944977B2 (en) | 2013-12-12 | 2018-04-17 | Raindance Technologies, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
| RU2601678C2 (en) * | 2014-12-15 | 2016-11-10 | Самсунг Электроникс Ко., Лтд. | Portable device for measurement of chromophores in skin and method of using said device |
| WO2016099099A1 (en) | 2014-12-15 | 2016-06-23 | Samsung Electronics Co., Ltd. | Image capturing device and sensing protection device |
| US10013527B2 (en) | 2016-05-02 | 2018-07-03 | Aranz Healthcare Limited | Automatically assessing an anatomical surface feature and securely managing information related to the same |
| US11116407B2 (en) | 2016-11-17 | 2021-09-14 | Aranz Healthcare Limited | Anatomical surface assessment methods, devices and systems |
| EP3606410B1 (en) | 2017-04-04 | 2022-11-02 | Aranz Healthcare Limited | Anatomical surface assessment methods, devices and systems |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139025A (en) * | 1983-10-14 | 1992-08-18 | Somanetics Corporation | Method and apparatus for in vivo optical spectroscopic examination |
| US5016173A (en) * | 1989-04-13 | 1991-05-14 | Vanguard Imaging Ltd. | Apparatus and method for monitoring visually accessible surfaces of the body |
| US5079698A (en) * | 1989-05-03 | 1992-01-07 | Advanced Light Imaging Technologies Ltd. | Transillumination method apparatus for the diagnosis of breast tumors and other breast lesions by normalization of an electronic image of the breast |
| US5845639A (en) * | 1990-08-10 | 1998-12-08 | Board Of Regents Of The University Of Washington | Optical imaging methods |
| US5353790A (en) * | 1992-01-17 | 1994-10-11 | Board Of Regents, The University Of Texas System | Method and apparatus for optical measurement of bilirubin in tissue |
| IL108350A0 (en) * | 1993-01-19 | 1994-04-12 | Computer Aided Medical Inc | Diagnostic imaging method and device |
| US5440388A (en) * | 1993-08-02 | 1995-08-08 | Erickson; Jon W. | Chemical analysis and imaging by discrete fourier transform spectroscopy |
| DE4427101A1 (en) * | 1994-07-30 | 1996-02-01 | Boehringer Mannheim Gmbh | Apparatus and method for the optical characterization of the structure and composition of a scattering sample |
| US6081612A (en) * | 1997-02-28 | 2000-06-27 | Electro Optical Sciences Inc. | Systems and methods for the multispectral imaging and characterization of skin tissue |
-
1996
- 1996-11-19 GB GBGB9624003.1A patent/GB9624003D0/en active Pending
-
1997
- 1997-11-19 ES ES97912388T patent/ES2175373T3/en not_active Expired - Lifetime
- 1997-11-19 GB GB9910980A patent/GB2334099B/en not_active Expired - Fee Related
- 1997-11-19 WO PCT/GB1997/003177 patent/WO1998022023A1/en active IP Right Grant
- 1997-11-19 IL IL13000897A patent/IL130008A/en not_active IP Right Cessation
- 1997-11-19 BR BR9713097-4A patent/BR9713097A/en active Search and Examination
- 1997-11-19 JP JP52335798A patent/JP2001504020A/en active Pending
- 1997-11-19 CA CA002272290A patent/CA2272290C/en not_active Expired - Fee Related
- 1997-11-19 AU AU49615/97A patent/AU725766B2/en not_active Ceased
- 1997-11-19 DE DE69712533T patent/DE69712533T2/en not_active Expired - Lifetime
- 1997-11-19 EP EP97912388A patent/EP1006876B1/en not_active Expired - Lifetime
- 1997-11-19 AT AT97912388T patent/ATE217172T1/en not_active IP Right Cessation
-
1999
- 1999-05-19 US US09/314,751 patent/US6324417B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU725766B2 (en) | 2000-10-19 |
| ES2175373T3 (en) | 2002-11-16 |
| JP2001504020A (en) | 2001-03-27 |
| GB9624003D0 (en) | 1997-01-08 |
| WO1998022023A1 (en) | 1998-05-28 |
| EP1006876A1 (en) | 2000-06-14 |
| DE69712533T2 (en) | 2002-08-29 |
| GB9910980D0 (en) | 1999-07-14 |
| US6324417B1 (en) | 2001-11-27 |
| BR9713097A (en) | 2000-03-28 |
| AU4961597A (en) | 1998-06-10 |
| ATE217172T1 (en) | 2002-05-15 |
| DE69712533D1 (en) | 2002-06-13 |
| EP1006876B1 (en) | 2002-05-08 |
| IL130008A0 (en) | 2000-02-29 |
| CA2272290A1 (en) | 1998-05-28 |
| GB2334099B (en) | 2000-12-27 |
| IL130008A (en) | 2003-11-23 |
| GB2334099A (en) | 1999-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2272290C (en) | Method for measurement of skin histology | |
| US7647085B2 (en) | Method of and apparatus for investigating tissue histology | |
| US9215984B2 (en) | Multispectral imaging for quantitative contrast of functional and structural features of layers inside optically dense media such as tissue | |
| Heusmann et al. | Characterization of female breasts in vivo by time-resolved and spectroscopic measurements in the near infrared spectroscopy | |
| Claridge et al. | From colour to tissue histology: physics-based interpretation of images of pigmented skin lesions | |
| US11653874B2 (en) | Method and system for characterizing tissue in three dimensions using multimode optical measurements | |
| US20150374309A1 (en) | Method and system for characterizing tissue in three dimensions using multimode optical measurements | |
| EP1185853B1 (en) | Method of and apparatus for investigating tissue histology | |
| EP2050385B1 (en) | Method and apparatus for measuring collagen thickness | |
| Hughes et al. | Use of reflectance spectrophotometry and colorimetry in a general linear model for the determination of the age of bruises | |
| EP0832422B1 (en) | Method and apparatus for detecting and measuring conditions affecting color | |
| US6128516A (en) | Method and apparatus for detecting and measuring conditions affecting color | |
| Claridge et al. | From colour to tissue histology: Physics based interpretation of images of pigmented skin lesions | |
| Setiadi et al. | A new LED-based multispectral imaging system for blood and melanin content estimation: The validation | |
| JPH11299743A (en) | Method and apparatus for determination of components in skin | |
| MacKinnon et al. | In vivo skin chromophore mapping using a multimode imaging dermoscope (SkinSpect™) | |
| EP3351162A1 (en) | A computer implemented method, a system and computer program products to characterize a skin lesion | |
| D’Alessandro et al. | Depth-dependent hemoglobin analysis from multispectral transillumination images | |
| D'Alessandro et al. | Multispectral transillumination imaging of skin lesions for oxygenated and deoxygenated hemoglobin measurement | |
| Yang et al. | An imaging colorimeter for noncontact skin color measurement | |
| MXPA99004657A (en) | Method for measurement of skin histology | |
| Välisuo et al. | The colour of blood in skin: a comparison of Allen's test and photonics simulations | |
| McGuiness et al. | Developing an accurate system of measuring colour in a venous leg ulcer in order to assess healing | |
| Baran et al. | COMPUTERIZED IMAGE ANALYSIS OF NAILS A-Ecrɛ ɔ psy FUNGAL INFECTION: EVALUATION USING DIGITAL P-oro: pApps | |
| AU2003276422A1 (en) | Methods and apparatus for measuring tissue histology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20131119 |